Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans

Journal of Molecular Biology

Volumn 261, Issue 1, 1996, Pages 11-22

  Valadon, Philippe ^a   Nussbaum, Gabriel ^a   Boyd, Lisa F ^b   Margulies, David H ^b   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antibody; Cryptococcus; Peptide library; Phage; Polysaccharide

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE; POLYSACCHARIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DISSOCIATION CONSTANT; FUNGUS; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0030576498     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0438     Document Type: Article

References (38)

1. Adey, N. B., Mataragnon, A. H., Rider, J. E., Carter, J. M. & Kay, B. K. (1995). Characterization of phage that bind plastic from phage-displayed random peptide libraries. Gene, 156, 27-31.
2. Barrett, R. W., Cwirla, S. E., Ackerman, M. S., Olson, A. M., Peters, E. A. & Dower, W. J. (1992). Selective enrichment and characterization of high affinity ligands from collections of random peptides on filamentous phage. Anal. Biochem. 204, 357-364.
3. Bona, C. (1993). Molecular characteristics of anti-polysaccharide antibodies. Springer Semin. Immunopathol. 15, 103-118.
4. Casadevall A. (1995). Antibody immunity and invasise fungal infections. Infect. Immun. 63, 4211-4218.
5. Casadevall, A. & Scharff, M. D. (1991). The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J. Exp. Med. 174, 151-160.
6. Casadevall, A. & Scharff, M. D. (1994). Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob. Agents Chemother. 38, 1695-1702.
7. Casadevall, A., Mukherjee, J., Devi, S. J., Schneerson, R., Robbins, J. B. & Scharff, M. D. (1992a). Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 165, 1086-1093.
8. Casadevall, A., Mukherjee, J. & Scharff, M. D. (1992b). Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods, 154, 27-35.
9. Cherniak, R. & Sundstrom, J. B. (1994). Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62, 1507-1512.
10. Corr, M., Boyd, L. F., Frankel, S. R., Kozlowski, S., Padlan, E. A. & Margulies, D. H. (1992). Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular, modeling of the complex. J. Exp. Med. 176, 1681-1692.
11. Corr, M., Boyd, L. F., Padlan, E. A. & Margulies, D. H. (1993). H-2Dd exploits a four residue peptide binding motif. J. Exp. Med. 178, 1877-1892.
12. Corr, M., Slanetz, A. E., Boyd, L. F., Jelonek, M. T., Khilko, S., al-Ramadi, B. K., Kim, Y. S., Maher, S. E., Bothwell, A. L. & Margulies, D. H. (1994). T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science, 265, 946-949.
13. Cwirla, S. E., Peters, E. A., Barrett, R. W. & Dower, W. J. (1990). Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl Acad. Sci. USA, 87, 6378-6382.
14. Dromer, F., Charreire, J., Contrepois, A., Carbon, C. & Yeni, P. (1987). Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55, 749-752.
15. Evans, S. V., Rose, D. R., To, R., Young, N. M. & Bundle, D. R. (1994). Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab. J. Mol. Biol. 241, 691-705.
16. Harlow, E. & Lane, D. (1988). Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Hoess, R., Brinkmann, U., Handel, T. & Pastan, I. (1993). Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene, 128, 43-49.
18. Ikeda, R., Shinoda, T., Fukazawa, Y. & Kaufman, L. (1982). Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J. Clin. Microbiol. 6, 22-29.
19. Lane, D. P. & Stephen, C. W. (1993). Epitope mapping using bacteriophage peptide libraries. Curr. Opin. Immunol. 5, 268-271.
20. Mukherjee, J., Scharff, M. D. & Casadevall, A. (1992). Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60, 4534-4541.
21. Mukherjee, J., Casadevall, A. & Scharff, M. D. (1993). Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177, 1105-1116.
22. Mukherjee, J., Zuckier, L. S., Scharff, M. D. & Casadevall, A. (1994). Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob. Agents Chemother. 38, 580-587.
23. Mukherjee, J., Nussbaum, G., Scharff, M. D. & Casadevall, A. (1995a). Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181, 405-409.
24. Mukherjee, S., Lee, S. C. & Casadevall, A. (1995b). Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63, 573-579.
25. Oldenburg, K. R., Loganathan, D., Goldstein, I. J., Schultz, P. G. & Gallop, M. A. (1992). Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl Acad. Sci. USA, 89, 5393-5397.
26. Padlan, E. A. (1990). On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Protein, 7, 112-124.
27. Parmley, S. F. & Smith, G. P. (1988). Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene, 73, 305-318.
28. Sambrook, J., Fritsch, E. F. & Maniatis, T., editors (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Sanford, J. E., Lupan, D. M., Schlageter, A. M. & Kozel, T. R. (1990). Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect. Immun. 58, 1919-1923.
30. Sanger, F., Nicklen, S. & Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA, 74, 5463-5467.
31. Scott, J. K. & Smith, G. P. (1990). Searching for peptide ligands with an epitope library. Science, 249, 386-390.
32. Scott, J. K., Loganathan, D., Easley, R. B., Gong, X. & Goldstein, I. J. (1992). A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl Acad. Sci. USA, 89, 5398-5402.
33. Smith, G. P. & Scott, J. K. (1993). Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217, 228-257.
34. Valadon, P. & Scharff, M. D. (1996). Enhancement of ELISAs for screening peptides in epitope phage display libraries. J. Immunol. Methods, in the press.
35. Westerink, M. A. & Apicella, M. A. (1993). Anti-idiotypic antibodies as vaccines against carbohydrate antigens. Springer Semin. Immunopathol. 15, 227-234.
36. Westerink, M. A., Giardina, P. C., Apicella, M. A. & Kieber-Emmons, T. (1995). Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl Acad. Sci. USA, 92, 4021-4025.
37. Yuan, R., Casadevall, A., Spira, G. & Scharff, M. D. (1995). Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154, 1810-1816.
38. Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. & Rahal, J. J. (1986). Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann. Intern. Med. 104, 234-240.